|
LARP1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.657600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.387000E-01 |
| Normal-vs-Stage2 |
5.356800E-01 |
| Normal-vs-Stage3 |
2.801800E-01 |
| Normal-vs-Stage4 |
5.735800E-01 |
| Stage1-vs-Stage2 |
1.917040E-01 |
| Stage1-vs-Stage3 |
7.123400E-01 |
| Stage1-vs-Stage4 |
9.336600E-01 |
| Stage2-vs-Stage3 |
1.895780E-01 |
| Stage2-vs-Stage4 |
4.390200E-01 |
| Stage3-vs-Stage4 |
7.696800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.757600E-01 |
| Normal-vs-AfricanAmerican |
1.341920E-02 |
| Normal-vs-Asian |
4.285800E-01 |
| Caucasian-vs-AfricanAmerican |
1.944320E-02 |
| Caucasian-vs-Asian |
4.405400E-01 |
| AfricanAmerican-vs-Asian |
9.787000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.972400E-01 |
| Normal-vs-Female |
4.563400E-01 |
| Male-vs-Female |
9.365000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.270100E-02 |
| Normal-vs-Extreme_Weight |
3.593400E-01 |
| Normal-vs-Obese |
6.978400E-01 |
| Normal-vs-Extreme_Obese |
6.586800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.171600E-01 |
| Normal_Weight-vs-Obese |
2.172000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.579170E-01 |
| Extreme_Weight-vs-Obese |
6.814400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.894800E-01 |
| Obese-vs-Extreme_Obese |
5.693600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.048200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.327200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.320800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.345230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.153400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.904360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.620830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.384800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.563800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.874800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.327200E-01 |
| Normal-VS-Type2 PRCC |
1.003030E-01 |
| Normal-VS-KIRP CIMP |
3.408400E-01 |
| Normal-VS-Unclassified PRCC |
7.764600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.307200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.382750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.711600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.680100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.211790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.342800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.978200E-02 |
| Normal-vs-N1 |
9.294200E-01 |
| Normal-vs-N2 |
2.716800E-01 |
| N0-vs-N1 |
3.016400E-01 |
| N0-vs-N2 |
8.740200E-01 |
| N1-vs-N2 |
5.660800E-01 |
|
|
